GH therapy does not alter the IGF-I/IGFBP-3 molar ratio in GH deficient (GHD) children.: Results from a 2-yrs prospective longitudinal study

被引:0
|
作者
Scire, Giuseppe [1 ]
Del Bianco, Chiara [1 ]
Spadoni, Gian Luigi [1 ]
Cianfarani, Stefano [1 ]
机构
[1] Univ Roma Tor Vergata, Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:154 / 154
页数:1
相关论文
共 14 条
  • [1] IGF-I and IGFBP-3 as markers for monitoring GH therapy in GH-deficient children
    Boettcher, Claudia
    Shavrikova, Elena P.
    Crowe, Brenda J.
    Wudy, Stefan A.
    Blum, Werner F.
    HORMONE RESEARCH, 2008, 70 : 99 - 99
  • [2] Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents
    Ranke, MB
    Schweizer, R
    Elmlinger, MW
    Weber, K
    Binder, G
    Schwarze, CP
    Wollmann, HA
    HORMONE RESEARCH, 2001, 55 (03) : 115 - 124
  • [3] Ghrelin concentration is correlated with IGF-I/IGFBP-3 molar ratio but not with GH secretion in children with short stature
    Stawerska, Renata
    Smycznska, Joanna
    Czkwianianc, Elzbieta
    Pisarek, Hanna
    Hilczer, Maciej
    Lewinski, Andrzej
    NEUROENDOCRINOLOGY LETTERS, 2012, 33 (04) : 412 - 418
  • [4] Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests
    Smyczynska, Joanna
    Hilczer, Maciej
    Stawerska, Renata
    Lewinski, Andrzej
    NEUROENDOCRINOLOGY LETTERS, 2013, 34 (03) : 222 - 228
  • [5] Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population
    Granada, ML
    Murillo, J
    Lucas, A
    Salinas, I
    Llopis, MA
    Castells, I
    Foz, M
    Sanmarti, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (03) : 243 - 253
  • [6] Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-I/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts
    Adiyaman, P
    Öcal, G
    Berberoglu, M
    Evliyaoglu, O
    Aycan, Z
    Çetinkaya, E
    Bulca, Y
    Ersöz, G
    Akar, N
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2004, 17 (06): : 895 - 903
  • [7] The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children
    Mandel, SH
    Moreland, E
    Rosenfeld, RG
    Gargosky, SE
    ENDOCRINE, 1997, 7 (03) : 351 - 360
  • [8] The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children
    Scott H. Mandel
    Erin Moreland
    Ron G. Rosenfeld
    Sharron E. Gargosky
    Endocrine, 1997, 7 : 351 - 360
  • [9] Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy
    Gabriela Ballerini, Maria
    Braslavsky, Debora
    Alejandra Scaglia, Paula
    Keselman, Ana
    Eugenia Rodriguez, Maria
    Martinez, Alicia
    Veronica Freire, Analia
    Mario Domene, Horacio
    Guillermo Jasper, Hector
    Bergada, Ignacio
    Gabriela Ropelato, Maria
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 (05): : 354 - 363
  • [10] Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severelv GH-deficient (GHD) patients after childhood GH treatment: A comparison with adult onset GFID patients
    Attanasio, AF
    Howell, S
    Bates, PC
    Frewer, P
    Chipman, J
    Blum, WF
    Shalet, SM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07): : 3368 - 3372